- Points
- 0
Serum Institute of India (SII) is propelling up aspiration for a new vaccine for corona virus. The Pune based institute claimed to achieve a progress in developing a vaccine for this frightening virus; they also assured that their developed vaccine has already reached to clinical trial stage on animals and results will come within 2 months.
The SII did a partnership in the previous month with the US biotech drug research company Codagenix to jointly prepare vaccine to combat the COVID-19 virus. They gave intimation that their vaccine would be marketized by 2021.
The estimated cost of the project is Rs 300 crore, but Serum Institute of India has targeted to obtain external funding through other global partners. This project will be controlled with ‘Bio Safety Level 3’ conditions – a highly restricted level. Very few facilities like ‘Serum Institute of India’ have huge amount of production controlled by ‘Bio Safety Level 3’ conditions. The total responsibility is on Codagenix to marketize the vaccine once it is ready.
Link not working so taken down
The SII did a partnership in the previous month with the US biotech drug research company Codagenix to jointly prepare vaccine to combat the COVID-19 virus. They gave intimation that their vaccine would be marketized by 2021.
The estimated cost of the project is Rs 300 crore, but Serum Institute of India has targeted to obtain external funding through other global partners. This project will be controlled with ‘Bio Safety Level 3’ conditions – a highly restricted level. Very few facilities like ‘Serum Institute of India’ have huge amount of production controlled by ‘Bio Safety Level 3’ conditions. The total responsibility is on Codagenix to marketize the vaccine once it is ready.
Link not working so taken down
Last edited by a moderator:
